Kinetic Catalytic Inhibition And Cell-Based Analysis, Not Just Target Binding, Are Required To Assess Kinase Selectivity Of Covalent Inhibitors: Comparable Btk Vs Tec Selectivity Profile For Ibrutinib And Acalabrutinib